APA

Muthumani K., Choo A. Y., Hwang D. S., Dayes N. S., Chattergoon M., Mayilvahanan S., Thieu K. P., Buckley P. T., Emmanuel J., Premkumar A. & Weiner D. B. (20060106). HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo. : Molecular therapy : the journal of the American Society of Gene Therapy.

Chicago

Muthumani Karuppiah, Choo Andrew Y, Hwang Daniel S, Dayes Nathanael S, Chattergoon Michael, Mayilvahanan Shanmugam, Thieu Khanh P, Buckley Peter T, Emmanuel Joann, Premkumar Arumugam and Weiner David B. 20060106. HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo. : Molecular therapy : the journal of the American Society of Gene Therapy.

Harvard

Muthumani K., Choo A. Y., Hwang D. S., Dayes N. S., Chattergoon M., Mayilvahanan S., Thieu K. P., Buckley P. T., Emmanuel J., Premkumar A. and Weiner D. B. (20060106). HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo. : Molecular therapy : the journal of the American Society of Gene Therapy.

MLA

Muthumani Karuppiah, Choo Andrew Y, Hwang Daniel S, Dayes Nathanael S, Chattergoon Michael, Mayilvahanan Shanmugam, Thieu Khanh P, Buckley Peter T, Emmanuel Joann, Premkumar Arumugam and Weiner David B. HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo. : Molecular therapy : the journal of the American Society of Gene Therapy. 20060106.